User:Avocado J/Avocado Pharma: Difference between revisions
Content deleted Content added
←Created page with '{{short description|US pharmaceutical company}} {{Infobox company | name = Avocado Pharma | logo = | logo_caption = | image = | image_caption = | type = P...' |
No edit summary |
||
| Line 32: | Line 32: | ||
| bodystyle = |
| bodystyle = |
||
}} |
}} |
||
'''Avocado Pharma''' is an American publicly traded [[biopharmaceutical]] company founded in |
'''Avocado Pharma''' is an American publicly traded [[biopharmaceutical]] company founded in 2030. It originated as a [[Corporate spin-off|spin-off]] of [[MMG Laboratories]]. |
||
Revision as of 13:49, 1 September 2020
| Company type | Public |
|---|---|
| Industry | Biopharmaceutical Pharmaceutical industry |
| Founded | 2030 |
| Founder | M. M. Gunathilake |
| Headquarters | Miami, Florida, Florida, United States |
Area served | Worldwide (180+ countries) |
Key people | M. M. Gunathilake (President) A. D. Gunathilake (CEO) C. B. Nugarae (Chairman) |
| Products | See list of Avocado Pharma products |
| Revenue |  US$110.059 billion (2032) |
| US$82.059 billion (2032) | |
| US$58.88 billion (2032) | |
| Total assets | US$198.321 billion (2032) |
| Total equity | US$92.102 billion (2032) |
Number of employees | 132,023 (2032) |
| Parent | Nugara Inc,. |
| Website | avocado |
Avocado Pharma is an American publicly traded biopharmaceutical company founded in 2030. It originated as a spin-off of MMG Laboratories.